Pulmonary Pathology Society

Pulmonary Pathology Sessions, 2008 IAP Congress, Athens, Greece Short Course on Lung cancer staging issues and targeted therapy in practice Chairs: Moises Espino Duran, Panama, J. Olufemi Ogunbiyi, Nigeria October 14, 2008, Problem areas of staging: Staging of synchronous carcinomas in the lung, William D. Travis, USA Problems of lymph node assessment in non-small-cell carcinoma and micrometastasis (“Sentinel Nodes”) Alberto Marchevsky, USA Bronchial margin assessment in lung cancer: how, when, why, and what are the key points? Douglas Flieder, USA BAC and minimally invasive “BAC” – are these equivalent? Sanja Dacic, Croatia/USA Signaling pathways in NSCLC and SCLC, Elisabeth Brambilla, France Predictors of therapy response in lung carcinomas, Ignacio Wistuba, Chile/USA EGFR and adenocarcinoma: What do we need to report? Montserrat Sanchez-Cespedes, Spain What, if any, immunohistochemical markers are important for lung cancer staging and prognosis, Ming Tsao, Canada Pulmonary vascular pathology update Chairs: Bruno Murer Italy, Mary Beth Beasley, USA The Venice classification – how to diagnose PAH, Katrien Gruenberg, Netherlands Mechanisms of idiopathic PAH Susan Stuart, UK Morphologic changes induced by PAH drugs, Rainer Bohle, Germany Systemic Diseases and PAH, Osamu Matsubara, Japan Thromboembolic pulmonary hypertension Henry Tazelaar, USA Airway changes in primary pulmonary vascular disease, Wim Timens, Netherlands Pulmonary lymphatic abnormalities Aliya Husain, USA Pulmonary hypertension in lung carcinomas, Alain Borczuk USA Lung in Systemic Diseases Chairs: Handan Zeren, Turkey, Julio Defaveri, Brazil Lung reactions in autoimmune diseases Masanori Kitaichi, Japan Non-infectious pulmonary manifestations of AIDS Helen Wainwright South Africa Alveolar hemorrhage syndrome and its underlying causes, Vera Capelozzi, Brazil Systemic diseases involving heart and lung Marie Christine Aubry, USA Pulmonary manifestations of cutaneous disease Eugene Mark, USA Hypersensitivity Pneumonia Moises Selman, Mexico Role of matrix metalloproteases in lung remodeling associated to idiopathic and collagen-vascular diseases Annie Pardo, Mexico Drug induced lung disease Teri Franks, USA Short Course on Mesothelioma Chairs: Philip T. Cagle, USA, Sang Ho Cho, Korea Current perspectives on the pathogenesis of malignant mesothelioma, Brooke Mossman, USA Unusual histologic patterns of Malignant Mesothelioma, Douglas Henderson, Australia Update on useful immunohistochemical and molecular markers in malignant mesothelioma, Toshiaki Kawai, Japan Non-asbestos-related malignant mesotheliomas – causes, histologic characteristics, distinguishing features, Funda Demirag, Turkey Surgical approaches to malignant mesothelioma – pathologic study and prognosis Francoise Galateau-Salle, France Signalling pathways in mesotheliomas and new horizons for treatment, Helmut H. Popper, Austria Asbestos exposure and carcinogenesis, Richard L. Attanoos, UK

Pulmonary Pathology Society (PPS)
A Division of the American Society for Investigative Pathology (ASIP) www.asip.org
9650 Rockville Pike, Bethesda, MD 20814-3993 (USA)
Tel: 301-634-7926, Fax: 301-634-7990, Email: pps@asip.org
www.pulmonarypath.org

©Copyright 2006, Pulmonary Pathology Society. All Rights Reserved
.......